Beyond cancer, CDKs are implicated in other diseases. For example, CDK5 is involved in neurodegenerative diseases such as Alzheimer's. CDK5 dysregulation leads to abnormal phosphorylation of neuronal proteins, contributing to neurodegeneration. Consequently, CDK5 inhibitors are being explored as potential treatments for neurodegenerative disorders.
